Personalized Medicine
Personalized Medicine
Introduction to Biology
This paper focuses on the representation of the personalized medicine and how the modern techno-scientific has lead for its evolution. Personalized medicine refers to contemporary techno-scientific advantages in modern medicine, such as vitro fertilization technologies, organ transplantation, stem cell therapy, complex life support technologies, etc. The point here is that these and related developments not only continue to stretch and design life, and to boost life expectancy statistics, especially in advanced countries, but they also pose ethical challenges, disadvantages and support a dichotomous relationship between longevity and quality of life.
For example, with hundreds of thousands of test tube babies living in the world, in vitro fertilization (IVF) has become much more common. IVF is usually reserved for instances in which a woman suffers from blocked or damaged fallopian tubes or a man has low sperm count.
The typical IVF cycle begins with drug treatment designed to control ovulation. One common method is to take five days of nasally administered gonadotropin-releasing hormone analogue (GnRH) to shut down the ovaries, followed by then days of injections of follicle-stimulation hormone (FSH) designed to spur the production of multiple eggs.
Blood tests and ultrasound exams help determine the best time to remove the eggs from follicles in the ovaries, which is done surgically bout 36 hours after an injection of human chorionic gonadotropin (hCG). The eggs are then mixed with sperm from the patient’s partner has been donated that same day, and the mixture is incubated in a glass dish for 2-5 days as the fertilized eggs develop. Then selected eggs are placed in the patient’s uterus by means of a catheter inserted through the vagina and cervix, and the patient remains in bed for the next several hours.
Vitro fertilization technology is a great model of modern medicine; however, there are many risks
Introduction to Biology
This paper focuses on the representation of the personalized medicine and how the modern techno-scientific has lead for its evolution. Personalized medicine refers to contemporary techno-scientific advantages in modern medicine, such as vitro fertilization technologies, organ transplantation, stem cell therapy, complex life support technologies, etc. The point here is that these and related developments not only continue to stretch and design life, and to boost life expectancy statistics, especially in advanced countries, but they also pose ethical challenges, disadvantages and support a dichotomous relationship between longevity and quality of life.
For example, with hundreds of thousands of test tube babies living in the world, in vitro fertilization (IVF) has become much more common. IVF is usually reserved for instances in which a woman suffers from blocked or damaged fallopian tubes or a man has low sperm count.
The typical IVF cycle begins with drug treatment designed to control ovulation. One common method is to take five days of nasally administered gonadotropin-releasing hormone analogue (GnRH) to shut down the ovaries, followed by then days of injections of follicle-stimulation hormone (FSH) designed to spur the production of multiple eggs.
Blood tests and ultrasound exams help determine the best time to remove the eggs from follicles in the ovaries, which is done surgically bout 36 hours after an injection of human chorionic gonadotropin (hCG). The eggs are then mixed with sperm from the patient’s partner has been donated that same day, and the mixture is incubated in a glass dish for 2-5 days as the fertilized eggs develop. Then selected eggs are placed in the patient’s uterus by means of a catheter inserted through the vagina and cervix, and the patient remains in bed for the next several hours.
Vitro fertilization technology is a great model of modern medicine; however, there are many risks
References: Elective Single-Embryo Transfer versus Double-Embryo Transfer in in Vitro Fertilization. (2004, December 2). Retrieved August 2, 2012, from The New England Journal of Medicine : http://www.nejm.org/doi/full/10.1056/NEJMoa041032 General Article: In Vitro Fertilization Today. (2010). Retrieved August 12, 2012, from WGBH Educational Foundation: http://www.pbs.org/wgbh/americanexperience/features/general- article/babies-today/ Oguamanan, C. (2009). Personalized Medicine and Complementary and Alternative Medicine: In Search of Common Grounds. Journal of Alternative & Complementary Medicine , 943-949. Personalize Medicine: A Patient - Centered Paradigm. (n.d.). Journal of Translational Medicine , 206-208.